Marie Philipneri is a Nephrology physician affiliated with Saint Louis University. OpenAlex indexes 41 publications with 247 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
915 N Grand Blvd
Saint Louis, MO 631061621
Telephone
314-652-4100Provider last certified this registry record 11 Mar 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NXSTAGE MEDICAL, INC.Program year20241 payment
- Fresenius USA Marketing, Inc.Program year20241 payment
- Acera Surgical, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.8%Calcium channel blocker15%Amlodipine Besylate64%Nifedipine Er21%Amlodipine-Valsartan15%Part D<11 patientsBeta blocker11.8%Carvedilol65%Metoprolol Succinate19%Labetalol Hcl16%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
12.6%Potassium supplement5.5%Potassium Chloride100%Part D<11 patientsProton pump inhibitor2.8%Pantoprazole Sodium100%Part D<11 patients+ 2 more classes in this area
Other
6.6%Drugs for treatment of hyperkalemia and hyperphosphatemia4.1%Auryxia56%Lokelma44%Part D<11 patientsPhosphate Binder2.5%Sevelamer Carbonate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patient-Reported Concerns and Worrying About Kidney Conditions and APOL1 High-Risk Genotypes: A Midwestern US Cohort Study of Black Americans
Journal of the American Society of Nephrology
2025 - APOL1 Genetic Testing, Family History of Hypertension and Kidney Disease, and Renal Risk Variant Distributions in a Midwestern US Cohort
Journal of the American Society of Nephrology
2025 - Show Me CKDintercept Initiative: A Collective Impact Approach to Improve Population Health in Missouri
Mayo Clinic Proceedings Innovations Quality & Outcomes
2024 - “I Feel My Catheter Moving Around”: A clue for the diagnosis of late pregnancy while on peritoneal dialysis
Peritoneal Dialysis International
2024 - APOL1 Genotyping, Knowledge, and Attitudes among African American Patients: Building a Cohort in a Midwestern US Urban Community
Journal of the American Society of Nephrology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Belshe, MD
Saint Louis University
Mark Dykewicz, MD
Saint Louis University
Robert Gatter, MD, FACP, MACR
Saint Louis University
Keith Naunheim, MD
Saint Louis University
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”